Presentation is loading. Please wait.

Presentation is loading. Please wait.

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

Published byΤίτος Σπανού Modified over 4 years ago

Similar presentations

Presentation on theme: "Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi."— Presentation transcript:

1 Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi Matsunaga, MD, Kazuya Takamochi, MD, Shiaki Oh, MD  The Annals of Thoracic Surgery  Volume 98, Issue 2, Pages (August 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Typical images of part-solid lung cancer on thin-section CT scan. These lesions were proved to present VPI pathologically. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival curves for patients with surgically resected pure-solid lung cancers less than 30 mm in diameter based on thin-section computed tomographic findings. A statistically significant difference was observed between the outcomes with and without visceral pleural invasion (5-year overall survival rate, 81.3% vs 70.1%; log-rank test; p = ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival curves for patients with surgically resected part-solid lung cancers less than 30 mm in diameter based on thin-section computed tomographic findings. A statistically significant difference was not observed between the outcomes with and without visceral pleural invasion (5-year overall survival rate, 94.9% vs 85.6%; log-rank test; p = ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi."

Similar presentations

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Left Video-Assisted Thoracoscopic Surgery Esophagectomy in a Patient With Situs Inversus Totalis and Kartagener Syndrome  John Peel, BHSc, Gail Darling,

Left Video-Assisted Thoracoscopic Surgery Esophagectomy in a Patient With Situs Inversus Totalis and Kartagener Syndrome  John Peel, BHSc, Gail Darling,
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,
Bryan L. Walker, BS, Christina Williamson, MD, Shawn M

Bryan L. Walker, BS, Christina Williamson, MD, Shawn M
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Abdominal Compartment Syndrome After Late Repair of Bochdalek Hernia

Abdominal Compartment Syndrome After Late Repair of Bochdalek Hernia
Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias  Mariko Fukui, PhD, Kazuya Takamochi, PhD, Shiaki.

Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias  Mariko Fukui, PhD, Kazuya Takamochi, PhD, Shiaki.
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical Course  Sook Hwan Sung, MD, Jee-Won Chang, MD, Jhingook Kim, MD, Kyung Soo Lee, MD,

Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical Course  Sook Hwan Sung, MD, Jee-Won Chang, MD, Jhingook Kim, MD, Kyung Soo Lee, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System  Kazuya Takamochi, MD, Kota Imashimizu, MD, Mariko.

Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System  Kazuya Takamochi, MD, Kota Imashimizu, MD, Mariko.
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Similar presentations

Ads by Google